| | POLISH FINANCIAL SUPERVISION AUTHORITY | |
| | | | | UNI - EN REPORT No | 47 | / | 2016 | | | |
| | Date of issue: | 2016-05-19 | | | | | | | | |
| | Short name of the issuer | | | | | | | |
| | SOPHARMA AD | |
| | Subject | | | | | | | | | | |
| | Notification - current report 47 | |
| | Official market - legal basis | | | | | | |
| | Inne uregulowania | |
| | Unofficial market - legal basis | | | | | |
| | Contents of the report: | | | | | | | | |
| | We would like to notify you that on 16 May 2016 expired the three-month period under art. 157b of the POSA after the completion of the tender offer, in which each shareholder who did not participate in the tender offer may request from Sopharma AD to buy their shares with voting rights. The price per share of Medica AD in the proposal under art. 157a and upon the execution of the shareholder rights under art. 157b under the provisions of art. 157a par. 3 was equal to the price in the conducted tender offer of 3.50 BGN per share.
As a result of the conducted tender offer and after the completion of the transactions with shareholders in the period under art. 157b, Sopharma AD has bought a total of 3,135,006 shares and directly owns 97.94% of the shares with voting rights of Medica AD.
| |
| | Annexes | | | | | | | | | | |
| | File | Description | |
| | | Notification - current report 47 | |
+0,17% +0,74gr
-0,30% -1,19gr
